Compounded GLP-1 to Brand-Name: Your Transition Guide
The FDA is ending the compounded GLP-1 era. Here's your complete guide to transitioning to FDA-approved alternatives — Foundayo, Ozempic, Wegovy, Zepbound, or Mounjaro.
Why You Must Switch Now
The compounded GLP-1 market is facing an existential crisis:
- FDA has removed semaglutide from the shortage list — compounding pharmacies lose their legal exemption
- Lilly is aggressively litigating against tirzepatide compounders
- Quality is inconsistent — FDA has documented wide dose variability in compounded products
- Your supply could end any day — pharmacies are shutting down with little notice
Don't wait for a forced transition. Plan your switch now.
Compare Your Brand-Name Options
| Option | Form | List Price | Best For |
|---|---|---|---|
| Foundayo | Daily pill | $149-349/mo | Lowest cost, oral convenience |
| Ozempic | Weekly injection | $936/mo | Staying on semaglutide |
| Wegovy | Weekly injection or pill | $1,349/mo | Max semaglutide weight loss |
| Zepbound | Weekly injection | $1,059/mo | Max weight loss (tirzepatide) |
For most patients on compounded GLP-1s, Foundayo is the best transition: affordable, oral, no food restrictions, and FDA-approved.
Insurance & Savings Cards
Brand-name GLP-1s have manufacturer savings programs that can dramatically reduce cost:
- Lilly (Foundayo, Zepbound): Savings card at LillyDirect.com — as low as $25/month for insured patients
- Novo Nordisk (Ozempic, Wegovy): Savings card — as low as $25/month for commercially insured patients
- Without insurance: Foundayo at $149-349/month (dose-dependent) is the most affordable option at list price
Step-by-Step: How to Make the Switch
Calculate Your Personalized Switch Plan
Enter your current medication and dose to get a detailed switching plan with dose mapping, timeline, and cost analysis.
Frequently Asked Questions
Sources & Citations
- FDA statements on GLP-1 compounding enforcement
- FDA testing of compounded semaglutide quality (2024-2025)
- Manufacturer savings card programs (Lilly, Novo Nordisk)
Stay Updated
Get notified when Foundayo pricing changes, new GLP-1 options become available, or new switching data is published.
No spam. Unsubscribe anytime. We never share your email.
Ready to Make the Switch?
Talk to a doctor about switching to your new medication. These telehealth providers offer online consultations and GLP-1 prescriptions.
MedSwitcher may earn a commission from some providers. This does not affect our recommendations. Our switch plans are based on clinical data, not partnerships.